Early diagnosis and noninvasive monitoring of neurological disorders require sensitivity to elusive cellular-level ...
REGRETS, I’ve had a few. But possibly none greater than tear-trough filler. Unlike the late, great Frank Sinatra, however, I ...
The phase three clinical trial reached a milestone with its first American participant receiving treatment, advancing ...
Advances in Total-Body PET/CT Research. Journal of Biosciences and Medicines, 14, 274-282. doi: 10.4236/jbm.2026.141021 . PET ...
The Punch on MSN
AKUH: Kenyan hospital reshaping Africa’s healthcare landscape
In Nairobi, Kenya’s capital, the Aga Khan University Hospital is positioning itself to solve two of Africa’s nagging ...
On 16 January 2026, Telix Pharmaceuticals announced that the first U.S. patient had been dosed in BiPASS, a Phase 3 trial ...
In a proof-of-concept study, researchers from the Keck School of Medicine of USC and the California Institute of Technology ...
Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today announces that the first patient in the United States (U.S.) has been dosed ...
Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today announces that the first patient in the United States (U ...
Mr. Green, a 50-something businessman was asking a question I find myself answering on a surprisingly regular basis: “So, my PSA went up; what does that mean?” ...
Lumexa Imaging (LMRI) rated Buy: resilient outpatient imaging demand, hospital JV moat, and scale-driven FCF growth.
A nano-sized medicine boosts the anti-cancer immune response and eradicates tumors in mice. Researchers at Washington University School of Medicine in St. Louis, working with colleagues at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback